Notice bibliographique
- Notice
Type(s) de contenu et mode(s) de consultation : Texte noté : électronique
Titre(s) : Nutraceuticals [Texte électronique] : efficacy, safety, and toxicity / edited by Ramesh C. Gupta,... Rajiv Lall,... Ajay Srivastava,...
Édition : 2nd ed.
Publication : London : Academic press, copyright 2022
Description matérielle : 1 ressource dématérialisée
Note(s) : La pagination de l'édition imprimée correspondante est de : 1397 p.
Autre(s) auteur(s) : Gupta, Ramesh Chandra (1949-....). Éditeur scientifique
Lall, Rajiv. Éditeur scientifique
Srivastava, Ajay. Éditeur scientifique
Sujet(s) : Aliments fonctionnels
Indice(s) Dewey :
613.2 (23e éd.) = Diététique
Identifiants, prix et caractéristiques : ISBN 9780128212462. - ISBN 0128212462. - ISBN 9780128210383. - ISBN 0128210389
Identifiant de la notice : ark:/12148/cb47309498s
Notice n° :
FRBNF47309498
(notice reprise d'un réservoir extérieur)
Table des matières : Front Cover ; Nutraceuticals: Efficacy, Safety, and Toxicity ; Copyright Page
; Dedication ; Contents ; List of contributors ; Introduction ; References ;
I. Applications of nutraceuticals in common diseases and disorders ; 1 Nutraceuticals
in central nervous system diseases: potential mechanisms of neuroprotection ; Introduction
; Polyphenols ; Counteracting oxidative stress as a mechanism of neuroprotection
; Direct antioxidant action of quercetin ; Potential role of hormesis in neuroprotection
; Modulation of the Nrf2-ARE pathway as a mechanism of quercetin neuroprotection
Modulation of paraoxonase 2 as a potential novel mechanism of quercetin neuroprotection
; Paraoxonase 2 ; PON2 in the central nervous system ; Gender differences in PON2
expression ; Modulation of PON2 ; Modulation of PON2 by quercetin ; The issue of
metabolites ; RES and neuroprotection ; Ginkgo biloba and neuroprotection ; Concluding
remarks and future directions ; Acknowledgments ; References ; 2 Prevention of
neurodegenerative disorders by nutraceuticals ; Introduction ; Nutraceuticals for
the prevention and amelioration of Alzheimer disease
Nutraceuticals for the prevention and amelioration of Parkinson disease ; Nutraceuticals
for the prevention and amelioration of autism spectrum disorders ; Concluding remarks
and future directions ; References ; 3 Cognitive effects of nutraceuticals ; Introduction
; Biological basis of cognition ; Overview of cognition ; Cellular basis of information
storage ; Synaptic plasticity as a physical basis for memory ; Biological basis
of dementia ; Nutraceuticals with potential cognitive-enhancing functions ; Ginkgo
biloba ; Positive effects ; Potential mechanisms
Negative or null effects ; Bacopa monnieri ; Positive effects ; Potential mechanisms
; Negative or null effects ; Ginseng ; Positive effects ; Potential mechanism
; Negative or null effects ; Phosphatidylserine ; Positive effects ; Potential
mechanisms ; Negative or null effects ; Caffeine ; Positive effects ; Potential
mechanisms ; Negative or null effects ; Centella asiatica, Ephedra sinica, and Crocus
sativus ; Potential concerns of cognitive enhancement ; Concluding remarks and future
directions ; References ; 4 Nutraceuticals in anxiety and stress ; Introduction
Neurotransmitters, neuropeptides, and the HPA axis in stress and anxiety ; γ-Aminobutyric
acid ; Serotonin ; Dopamine ; Norepinephrine ; Cholecystokinin ; Oxytocin ;
Vasopressin ; HPA axis ; Dietary supplements in anxiety and stress ; Betulinic
acid ; Probiotics ; Protein hydrolysates ; Pheromones ; Omega-3 fatty acids ;
Melatonin ; Herbal extracts in calming ; Ginkgo biloba ; Ashwagandha (Withania
somnifera) ; Valerian (V. officinalis) ; Kava (Piper methysticum) ; Concluding
remarks and future directions ; References
